Adoption of Antifibrotic Medications: A Closer Look at the Data
- PMID: 33979262
- PMCID: PMC8522297
- DOI: 10.1513/AnnalsATS.202103-359LE
Adoption of Antifibrotic Medications: A Closer Look at the Data
Comment in
-
Reply: Adoption of Antifibrotic Medications: A Closer Look at the Data.Ann Am Thorac Soc. 2021 Oct;18(10):1757. doi: 10.1513/AnnalsATS.202104-516LE. Ann Am Thorac Soc. 2021. PMID: 33979273 Free PMC article. No abstract available.
Comment on
-
Adoption of the Antifibrotic Medications Pirfenidone and Nintedanib for Patients with Idiopathic Pulmonary Fibrosis.Ann Am Thorac Soc. 2021 Jul;18(7):1121-1128. doi: 10.1513/AnnalsATS.202007-901OC. Ann Am Thorac Soc. 2021. PMID: 33465323
References
-
- Dempsey TM, Payne S, Sangaralingham L, Yao X, Shah ND, Limper AH. Adoption of the anti-fibrotic medications pirfenidone and nintedanib for patients with idiopathic pulmonary fibrosis. Ann Am Thorac Soc. 2021 - PubMed
-
- Rogers EM. Diffusion of innovations. 5th ed. New York, NY: Free Press; 2003.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
